The Centers for Disease Control and Prevention Friday updated its April testing guidance for clinicians treating children with hepatitis of unknown cause. The agency is investigating 109 potential hepatitis cases of unknown cause in U.S. children since last October, including five deaths. More than 90% of the patients were hospitalized, 14% received liver transplants and more than half had a confirmed adenovirus infection, but officials still don’t know the actual cause of their hepatitis and cautioned that it may take time to assess the evidence and learn more. Potential cases also have been reported in the United Kingdom and other countries. 

Related News Articles

Headline
The Department of Health and Human Services Monday began accepting orders from states and other jurisdictions for a portion of 442,000 additional doses of the…
Headline
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Hawaii, Maryland and Ohio to extend postpartum coverage…
Headline
The Food and Drug Administration Friday said it does not recommend screening or testing blood donors for the monkeypox virus, given “the robustness” of…
Headline
The Department of Health and Human Services this week purchased $26 million worth of intravenous TPOXX (tecovirimat) to treat monkeypox, which the…
Headline
The Food and Drug Administration yesterday issued an emergency use authorization allowing health care providers to administer the JYNNEOS vaccine intradermally…
Headline
Health and Human Services Secretary Xavier Becerra today took action that will allow the Food and Drug Administration Commissioner to grant emergency use…